RA drug tapering may match standard dosing In a randomized trial, 88.2% of patients maintained low disease activity after dose reduction, although exploratory findings varied by drug class. By Andrea Surnit November 2, 2026 5 min MDSpire News Share Takeaways Listen Quiz Poll
